Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) was $3.19 for the day, down -0.93% from the previous closing price of $3.22. In other words, the price has decreased by -$0.93 from its previous closing price. On the day, 0.68 million shares were traded. ZNTL stock price reached its highest trading level at $3.32 during the session, while it also had its lowest trading level at $3.185.
Ratios:
Our analysis of ZNTL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.29 and its Current Ratio is at 7.29. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
On June 20, 2024, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $28 to $5.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 31 ’24 when Diana Hausman bought 9,888 shares for $2.86 per share.
Vultaggio Vincent sold 1,603 shares of ZNTL for $5,098 on Oct 04 ’24. The Principal Accounting Officer now owns 33,855 shares after completing the transaction at $3.18 per share. On May 31 ’24, another insider, Gallagher Cam, who serves as the President, Interim CFO of the company, sold 9,597 shares for $11.98 each. As a result, the insider received 114,972 and left with 633,680 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZNTL now has a Market Capitalization of 227336624 and an Enterprise Value of -134189800. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.75 while its Price-to-Book (P/B) ratio in mrq is 0.64. Its current Enterprise Value per Revenue stands at -3.308 whereas that against EBITDA is 0.645.
Stock Price History:
Over the past 52 weeks, ZNTL has reached a high of $18.07, while it has fallen to a 52-week low of $2.66. The 50-Day Moving Average of the stock is -4.06%, while the 200-Day Moving Average is calculated to be -51.23%.
Shares Statistics:
ZNTL traded an average of 1.26M shares per day over the past three months and 1197270 shares per day over the past ten days. A total of 71.15M shares are outstanding, with a floating share count of 57.60M. Insiders hold about 19.17% of the company’s shares, while institutions hold 83.16% stake in the company. Shares short for ZNTL as of 1732838400 were 4669830 with a Short Ratio of 4.37, compared to 1730332800 on 7052724. Therefore, it implies a Short% of Shares Outstanding of 4669830 and a Short% of Float of 13.19.
